The efficacy and safety of everolimus for the treatment of progressive gastroenteropancreatic neuroendocrine tumors: A multi-institution observational study in Taiwan.
about
Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors.Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives.Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea.
P2860
The efficacy and safety of everolimus for the treatment of progressive gastroenteropancreatic neuroendocrine tumors: A multi-institution observational study in Taiwan.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
The efficacy and safety of eve ...... observational study in Taiwan.
@en
The efficacy and safety of eve ...... observational study in Taiwan.
@nl
type
label
The efficacy and safety of eve ...... observational study in Taiwan.
@en
The efficacy and safety of eve ...... observational study in Taiwan.
@nl
prefLabel
The efficacy and safety of eve ...... observational study in Taiwan.
@en
The efficacy and safety of eve ...... observational study in Taiwan.
@nl
P2093
P2860
P356
P1476
The efficacy and safety of eve ...... observational study in Taiwan.
@en
P2093
Chang-Hsien Lu
Chien-Ting Liu
Fan-Chen Ku
Jen-Shi Chen
Li-Tzong Chen
Ming-Huang Chen
Wen-Chi Chou
Yan-Shen Shan
Yen-Yang Chen
P2860
P304
P356
10.1111/AJCO.12571
P50
P577
2016-06-30T00:00:00Z